TY - JOUR KW - Adult KW - Age Factors KW - Analgesics, Opioid/adverse effects KW - Blood Glucose/analysis KW - Confidence Intervals KW - Diabetes Mellitus/etiology/virology KW - Female KW - Hepatitis C/complications KW - HIV Infections/complications KW - Humans KW - Incidence KW - Logistic Models KW - Middle Aged KW - Odds Ratio KW - Opioid-Related Disorders/complications KW - Prevalence KW - Proportional Hazards Models KW - Prospective Studies KW - Risk Factors AU - A. A. Howard AU - D. R. Hoover AU - K. Anastos AU - X. Wu AU - Q. Shi AU - H. D. Strickler AU - S. R. Cole AU - M. H. Cohen AU - A. Kovacs AU - M. Augenbraun AU - P. S. Latham AU - P. C. Tien A1 - AB - BACKGROUND: Opiate use is common in HIV-infected and hepatitis C virus (HCV)-infected individuals, however, its contribution to the risk of diabetes mellitus is not well understood. METHODS: Prospective study of 1713 HIV-infected and 652 HIV-uninfected participants from the Women's Interagency HIV Study between October 2000 and March 2006. Diabetes defined as fasting glucose > or =126 mg/dL, self report of diabetes medication use, or confirmed diabetes diagnosis. Opiate use determined using an interviewer-administered questionnaire. Detectable plasma HCV RNA confirmed HCV infection. RESULTS: Current opiate users had a higher prevalence of diabetes (15%) than nonusers (10%, P = 0.03), and a higher risk of incident diabetes (adjusted relative hazard: 1.58, 95% confidence interval: 1.01 to 2.46), after controlling for HCV infection, HIV/antiretroviral therapy status, and diabetes risk factors including age, race/ethnicity, family history of diabetes, and body mass index. HCV infection was also an independent risk factor for diabetes (adjusted relative hazard: 1.61, 95% confidence interval: 1.02 to 2.52). HCV-infected women reporting current opiate use had the highest diabetes incidence (4.83 cases per 100 person-years). CONCLUSIONS: Among women with or at-risk for HIV, opiate use is associated with increased diabetes risk independently of HCV infection. Diabetic screening should be part of care for opiate users and those infected with HCV. BT - Journal of acquired immune deficiency syndromes (1999) C5 - Opioids & Substance Use CP - 2 CY - United States DO - 10.1097/QAI.0b013e3181d0c911 IS - 2 JF - Journal of acquired immune deficiency syndromes (1999) N2 - BACKGROUND: Opiate use is common in HIV-infected and hepatitis C virus (HCV)-infected individuals, however, its contribution to the risk of diabetes mellitus is not well understood. METHODS: Prospective study of 1713 HIV-infected and 652 HIV-uninfected participants from the Women's Interagency HIV Study between October 2000 and March 2006. Diabetes defined as fasting glucose > or =126 mg/dL, self report of diabetes medication use, or confirmed diabetes diagnosis. Opiate use determined using an interviewer-administered questionnaire. Detectable plasma HCV RNA confirmed HCV infection. RESULTS: Current opiate users had a higher prevalence of diabetes (15%) than nonusers (10%, P = 0.03), and a higher risk of incident diabetes (adjusted relative hazard: 1.58, 95% confidence interval: 1.01 to 2.46), after controlling for HCV infection, HIV/antiretroviral therapy status, and diabetes risk factors including age, race/ethnicity, family history of diabetes, and body mass index. HCV infection was also an independent risk factor for diabetes (adjusted relative hazard: 1.61, 95% confidence interval: 1.02 to 2.52). HCV-infected women reporting current opiate use had the highest diabetes incidence (4.83 cases per 100 person-years). CONCLUSIONS: Among women with or at-risk for HIV, opiate use is associated with increased diabetes risk independently of HCV infection. Diabetic screening should be part of care for opiate users and those infected with HCV. PP - United States PY - 2010 SN - 1944-7884; 1525-4135 SP - 152 EP - 159 EP - T1 - The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study T2 - Journal of acquired immune deficiency syndromes (1999) TI - The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study U1 - Opioids & Substance Use U2 - 20190642 U3 - 10.1097/QAI.0b013e3181d0c911 VL - 54 VO - 1944-7884; 1525-4135 Y1 - 2010 ER -